CureVac N.V. announced that the company's Chief Technology Officer, Dr. Mariola Fotin-Mleczek, will resign from CureVac effective January 31, 2022. Mariola exits her role at CureVac after nearly 16 years of scientific leadership at the company, and 33 years in Germany, with plans to pursue a family business outside the biotech industry in her home country of Poland.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | -10.02% | +15.42% | +6.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.65% | 1.01B | |
+51.85% | 57.87B | |
+41.22% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac Announces Resignation of Mariola Fotin-Mleczek as Chief Technology Officer